For the Inventor, By the Inventor

Enter assignee name

Dallas, TX, United States of America

Peloton Therapeutics, Inc.

USPTO Granted Patents = 18

EPO Patents = 8

Forward Citations = 114

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

John A Josey (13 out of 25 patents)

Hanbiao Yang (13 out of 13 patents)

Paul Wehn (12 out of 12 patents)

4. Eli M Wallace (12 out of 91 patents)

5. Bin Wang (11 out of 30 patents)

6. James P Rizzi (11 out of 44 patents)

7. Darryl David Dixon (9 out of 9 patents)

8. Jonas Grina (9 out of 9 patents)

9. Stephen T Schlachter (9 out of 48 patents)

10. Rui Xu (9 out of 33 patents)

11. Guangzhou Han (2 out of 2 patents)

12. Karl Bedke (2 out of 2 patents)

13. Xinlin Du (1 out of 1 patent)

14. Barry Goggin (1 out of 1 patent)

15. Peter J Stengel (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 12358870 - Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof (2025-07-15),

2. 12331068 - Compositions and methods for inhibiting CD73 (2025-06-17),

3. RE49948 - Aryl ethers and uses thereof (2024-04-30),

4. 11591355 - CD73 inhibitors and uses thereof (2023-02-28),

5. 10807948 - Aromatic compounds and uses thereof (2020-10-20),

6. 10786480 - Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof (2020-09-29),

7. 10597366 - Aryl ethers and uses thereof (2020-03-24),

8. 10512626 - Compositions for use in treating glioblastoma (2019-12-24),

9. 10335388 - Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof (2019-07-02),

10. 10278942 - Compositions for use in treating pulmonary arterial hypertension (2019-05-07),

11. 10155726 - Substituted pyridines and uses thereof (2018-12-18),

12. 10144711 - Aryl ethers and uses thereof (2018-12-04),

13. 10040767 - Benzimidazole derivatives and uses thereof (2018-08-07),

14. 9969689 - Aryl ethers and uses thereof (2018-05-15),

15. 9908845 - Aryl ethers and uses thereof (2018-03-06),

Peloton Therapeutics is a biopharmaceutical company dedicated to developing targeted small molecule drugs to treat cancer and other life-threatening diseases. Our lead drug candidate, PT2977, is an oral HIF-2α inhibitor currently being evaluated for the treatment of clear cell renal cell carcinoma (ccRCC) and other solid tumors. We are committed to advancing science and transforming patients' lives through innovative therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

18 Patents

#111 in Dallas, TX

#1,077 in Texas

#17,383 in US

#33,165 in the World

Dallas, TX, United States of America

Peloton Therapeutics, Inc.

Forward Citations = 114

18 inventors:

John A Josey (13 out of 25 patents)

Hanbiao Yang (13 out of 13 patents)

Paul Wehn (12 out of 12 patents)

4. Eli M Wallace (12 out of 91 patents)

5. Bin Wang (11 out of 30 patents)

Please report any incorrect information to support@idiyas.com

Loading…